Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction

NCT ID: NCT03139149

Last Updated: 2023-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-11

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the results of early surgery after 12 h conservative treatment and 48 h conservative treatment of adhesive small bowel obstruction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At the admission patients undergo abdomen x-ray, general and biochemical blood test and computer tomography (CT). After exclusion of indications for an emergency operation, patients are given a water-soluble contrast. Conservative treatment is carring out to 12 hours from admission. All patients with resolution of small bowel obstruction in 12 hours will be excluded from the research. Criteria for obstruction release of conservative treatment 1. No pain 2. Appearance of gas in the colon 3. Decrease of bloating 4. Contrast in the colon. After that, if obstruction is not resolved, randomization is performed. First group undergo surgery. Second group undergo conservative treatment with water-soluble contrast evaluation until 48 hours. In the second group surgery is performed if the conservative treatment is not effective. The results of early and late surgery and the results of conservative treatment in groups will be compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Small Bowel Obstruction Small Bowel Adhesion Strangulation of Ileum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early surgery

After exclusion of indications for an emergency operation, conservative treatment is performed up to 12 hours from the moment of admission. Each patient receive blood test, blood lactate investigation, blood biochemistry, X-ray of the abdomen, ultrasound and CT on the admission. Each patient receive water-soluble contrast in 3 h after admission. In case of of clinical and radiologic signs of obstruction in 12 h after admission, surgery is performed. On the first stage of surgical treatment laparoscopic adhesiolysis is performed. If it is impossible to eliminate the cause of obstruction by laparoscopic technique laparotomy is performed.

Group Type ACTIVE_COMPARATOR

Adhesiolysis

Intervention Type PROCEDURE

Method of video laparoscopic operation:

* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity

If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.

X-ray diagnostics

Intervention Type RADIATION

X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.

Computer tomography

Intervention Type RADIATION

Computer tomography of abdomen with iv contrast

Ultrasound

Intervention Type PROCEDURE

Ultrasound of the abdomen (2 times)

General and biochemical blood test

Intervention Type OTHER

General blood test and biochemical blood test 2 times a day

Late surgery

After exclusion of indications for an emergency operation, conservative treatment is performed up to 48 hours from the moment of admission. Each patient receive blood test, blood lactate investigation, blood biochemistry, X-ray of the abdomen, ultrasound and CT on the admission. Each patient receive water-soluble contrast 3 h after admission. In case of present of obstruction and absence of contrast in colon in 36 h after intake (48 h after admission) a surgery is perform. On the first stage of surgical treatment laparoscopic adhesiolysis is performed. If it is impossible to eliminate the cause of obstruction by laparoscopic technique laparotomy is performed.

Group Type ACTIVE_COMPARATOR

Adhesiolysis

Intervention Type PROCEDURE

Method of video laparoscopic operation:

* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity

If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.

X-ray diagnostics

Intervention Type RADIATION

X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.

Computer tomography

Intervention Type RADIATION

Computer tomography of abdomen with iv contrast

Ultrasound

Intervention Type PROCEDURE

Ultrasound of the abdomen (2 times)

General and biochemical blood test

Intervention Type OTHER

General blood test and biochemical blood test 2 times a day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adhesiolysis

Method of video laparoscopic operation:

* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity

If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.

Intervention Type PROCEDURE

X-ray diagnostics

X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.

Intervention Type RADIATION

Computer tomography

Computer tomography of abdomen with iv contrast

Intervention Type RADIATION

Ultrasound

Ultrasound of the abdomen (2 times)

Intervention Type PROCEDURE

General and biochemical blood test

General blood test and biochemical blood test 2 times a day

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with adhesive small bowel obstruction

Exclusion Criteria

Early postoperative small bowel obstruction Irreducible hernia Strangulation or peritonitis symptoms Impairment of consciousness Unstable hemodynamics
Minimum Eligible Age

17 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pirogov Russian National Research Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexander E. Tyagunov

MD. Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Moscow Clinical Hospital 1

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexander E Tyagunov, MD. Prof

Role: CONTACT

+79165022324

Alexander V Sazhin, PhD

Role: CONTACT

+79163904180

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Taras Nechay, PhD

Role: primary

+79268146829

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14121729

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.